A I Schafer

2.1k total citations
32 papers, 1.7k citations indexed

About

A I Schafer is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Physiology. According to data from OpenAlex, A I Schafer has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Hematology and 7 papers in Physiology. Recurrent topics in A I Schafer's work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Platelet Disorders and Treatments (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). A I Schafer is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Platelet Disorders and Treatments (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). A I Schafer collaborates with scholars based in United States, Switzerland and United Kingdom. A I Schafer's co-authors include Michael A. Gimbrone, William Durante, Michael H. Kroll, Burt Adelman, T. Harris, RI Handin, Joel L. Moake, Damian A. Brezinski, Geoffrey H. Tofler and James E. Muller and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

A I Schafer

31 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A I Schafer United States 18 553 445 384 266 247 32 1.7k
Francine Rendu France 31 1.4k 2.5× 400 0.9× 728 1.9× 258 1.0× 346 1.4× 108 2.9k
Fahumiya Samad United States 25 387 0.7× 421 0.9× 1.1k 2.8× 864 3.2× 260 1.1× 49 3.1k
Herbert Kühn Switzerland 19 215 0.4× 1.2k 2.7× 626 1.6× 422 1.6× 170 0.7× 57 2.3k
James D. Moffatt United Kingdom 22 820 1.5× 474 1.1× 669 1.7× 440 1.7× 247 1.0× 41 2.2k
Mark Wareing United Kingdom 30 240 0.4× 303 0.7× 421 1.1× 288 1.1× 485 2.0× 95 2.8k
Roger D. Nolan United States 17 131 0.2× 356 0.8× 514 1.3× 159 0.6× 97 0.4× 29 1.4k
Soochong Kim South Korea 26 1.1k 1.9× 715 1.6× 870 2.3× 143 0.5× 309 1.3× 99 2.5k
Brian Pedersen United States 17 800 1.4× 264 0.6× 504 1.3× 78 0.3× 335 1.4× 30 1.8k
Fujio Shimizu Japan 35 140 0.3× 464 1.0× 1.4k 3.7× 211 0.8× 569 2.3× 118 3.7k
Yoshio Oh-hashi Japan 15 142 0.3× 215 0.5× 422 1.1× 320 1.2× 147 0.6× 17 1.5k

Countries citing papers authored by A I Schafer

Since Specialization
Citations

This map shows the geographic impact of A I Schafer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A I Schafer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A I Schafer more than expected).

Fields of papers citing papers by A I Schafer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A I Schafer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A I Schafer. The network helps show where A I Schafer may publish in the future.

Co-authorship network of co-authors of A I Schafer

This figure shows the co-authorship network connecting the top 25 collaborators of A I Schafer. A scholar is included among the top collaborators of A I Schafer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A I Schafer. A I Schafer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
MacDougall, Andrew S., Paul Caplat, Johan Olofsson, et al.. (2021). Comparison of the distribution and phenology of Arctic Mountain plants between the early 20th and 21st centuries. Global Change Biology. 27(20). 5070–5083. 12 indexed citations
2.
Santisakultarm, Thom P., Tracy Stokol, Teresa Southard, et al.. (2014). Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in vivo two‐photon imaging. Journal of Thrombosis and Haemostasis. 12(12). 2120–2130. 36 indexed citations
3.
Schafer, A I. (2006). Thrombocytosis: When is an incidental finding serious?. Cleveland Clinic Journal of Medicine. 73(8). 767–774. 8 indexed citations
4.
Schafer, A I. (2001). Thrombocytosis and thrombocythemia. Blood Reviews. 15(4). 159–166. 68 indexed citations
5.
Durante, William & A I Schafer. (1998). Carbon monoxide and vascular cell function (review).. International Journal of Molecular Medicine. 2(3). 255–62. 89 indexed citations
6.
Schafer, A I. (1997). Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents.. PubMed. 24(2). 90–6. 7 indexed citations
7.
8.
Durante, William, Lan Liao, & A I Schafer. (1995). Differential regulation of L-arginine transport and inducible NOS in cultured vascular smooth muscle cells. American Journal of Physiology-Heart and Circulatory Physiology. 268(3). H1158–H1164. 39 indexed citations
9.
Durante, William, et al.. (1995). Ethanol potentiates interleukin-1 β-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells. Biochemical Journal. 308(1). 231–236. 35 indexed citations
10.
Durante, William, et al.. (1993). Endothelium-derived Relaxing Factor Inhibits Shear Stress-induced Platelet Aggregation. Platelets. 4(3). 135–140. 3 indexed citations
11.
Kroll, Michael H., et al.. (1993). Protein kinase C is activated in platelets subjected to pathological shear stress.. Journal of Biological Chemistry. 268(5). 3520–3524. 82 indexed citations
12.
Schafer, A I & Martin H. Kroll. (1993). Nonatheromatous Arterial Thrombosis. Annual Review of Medicine. 44(1). 155–170. 23 indexed citations
13.
Willich, Stefan N., Geoffrey H. Tofler, Damian A. Brezinski, et al.. (1992). Platelet alpha2 adrenoceptor characteristics during the morning increase in platelet aggregability. European Heart Journal. 13(4). 550–555. 15 indexed citations
14.
Kroll, Michael H., T. Harris, Joel L. Moake, RI Handin, & A I Schafer. (1991). von Willebrand factor binding to platelet GpIb initiates signals for platelet activation.. Journal of Clinical Investigation. 88(5). 1568–1573. 227 indexed citations
15.
Folts, John D., Bradford S. Schwartz, Michael H. Kroll, & A I Schafer. (1991). Streptokinase Inhibits Acute Platelet Thrombus Formation in Stenosed Dog Coronary Arteries. Platelets. 2(3). 145–152. 6 indexed citations
16.
Zavoico, George B., Bruce M. Ewenstein, A I Schafer, & J S Pober. (1989). IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis.. The Journal of Immunology. 142(11). 3993–3999. 68 indexed citations
17.
Schafer, A I, et al.. (1986). Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin.. Journal of Clinical Investigation. 78(1). 73–79. 106 indexed citations
18.
Schafer, A I & Burt Adelman. (1985). Plasmin inhibition of platelet function and of arachidonic acid metabolism.. Journal of Clinical Investigation. 75(2). 456–461. 125 indexed citations
19.
Gimbrone, Michael A., et al.. (1984). Leukotriene B4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells.. Journal of Clinical Investigation. 74(4). 1552–1555. 182 indexed citations
20.
Schafer, A I. (1973). Characteristics of college seniors planning careers in medicine. Academic Medicine. 48(9). 872–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francine Rendu Breakdown of academic impact, for papers by Fahumiya Samad Breakdown of academic impact, for papers by Herbert Kühn Breakdown of academic impact, for papers by James D. Moffatt Breakdown of academic impact, for papers by Mark Wareing Breakdown of academic impact, for papers by Roger D. Nolan Breakdown of academic impact, for papers by Soochong Kim Breakdown of academic impact, for papers by Brian Pedersen Breakdown of academic impact, for papers by Fujio Shimizu Breakdown of academic impact, for papers by Yoshio Oh-hashi
Rankless by CCL
2026